Manufacturers Life Insurance Company, The Verve Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 27,294 shares of VERV stock, worth $130,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,294
Previous 28,105
2.89%
Holding current value
$130,738
Previous $137,000
3.65%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VERV
# of Institutions
187Shares Held
73.4MCall Options Held
85KPut Options Held
215K-
Alphabet Inc. Mountain View, CA12.3MShares$59.2 Million4.09% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$31.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.96MShares$23.8 Million0.01% of portfolio
-
State Street Corp Boston, MA4.25MShares$20.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$19.2 Million0.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $287M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...